Angiosarcoma (AS) is a rare and aggressive disease originating from blood or lymphatic vessel endothelium, representing
Te-Lin Hsu, San-Chi Chen
doaj +1 more source
Abstracts of 14th International Symposium on Hodgkin Lymphoma
HemaSphere, Volume 10, Issue S2, October 2026.
wiley +1 more source
Wen-Chuan Lee1,*, Chih-Hsien Chang2,3,*, Chih-Min Huang1, Yu-Tse Wu1, Liang-Cheng Chen2, Chung-Li Ho2, Tsui-Jung Chang2, Te-Wei Lee2, Tung-Hu Tsai1,41Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, 2Division ...
Tsai TH +8 more
doaj
Combination of vinorelbine capsules and the small molecule anti-angiogenic drug apatinib for first-line treatment of advanced triple-negative breast cancer with schizophrenia after failure of anthracycline and taxane therapy: A case report. [PDF]
Bai X +7 more
europepmc +1 more source
Pharmacovigilance assessment of vinorelbine-associated adverse events using FAERS and VigiBase. [PDF]
Zhang Y +4 more
europepmc +1 more source
Identification of potential vinorelbine-associated prognostic genes in breast cancer through integrative bioinformatics and experimental validation. [PDF]
Wu Y, Yang G, Li Y, Ruan Y, Yang Q.
europepmc +1 more source
Efficacy and safety of first-line oral vinorelbine plus firmonertinib in refractory <i>EGFR</i>-mutated non-small cell lung cancer: study protocol of a multicenter, non-randomized, two-cohort study. [PDF]
Zhang B +8 more
europepmc +1 more source
Metastatic Malignant Mesothelioma of the Tunica Vaginalis Testis Treated With Sequential Immunotherapy, Chemotherapy, and Radiotherapy With Prolonged Disease Stabilisation: A Case Report. [PDF]
Mathiyalagan N +7 more
europepmc +1 more source
Efficacy and safety of metronomic oral vinorelbine in elderly patients with locally advanced and metastatic non-small cell lung cancer. [PDF]
Soliman SH, Atef MM.
europepmc +1 more source
Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer. [PDF]
Teramoto K +9 more
europepmc +1 more source

